In human prostate, a minor subgroup of “stem” cells (CD44+, Oct4+) expresses EZH2 and has been proposed to represent a cell reservoir for prostatic adenocarcinoma initiation [30]. The gene discussed is POU5F1; the disease is prostate adenocarcinoma.